Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments.


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
11 03 2020
Historique:
pubmed: 15 2 2020
medline: 14 5 2021
entrez: 15 2 2020
Statut: ppublish

Résumé

"Hot loop" protein segments have variable structure and conformation and contribute crucially to protein-protein interactions. We describe a new hot loop mimicking modality, termed PepNats, in which natural product (NP)-inspired structures are incorporated as conformation-determining and -restricting structural elements into macrocyclic hot loop-derived peptides. Macrocyclic PepNats representing hot loops of inducible nitric oxide synthase (iNOS) and human agouti-related protein (AGRP) were synthesized on solid support employing macrocyclization by imine formation and subsequent stereoselective 1,3-dipolar cycloaddition as key steps. PepNats derived from the iNOS DINNN hot loop and the AGRP RFF hot spot sequence yielded novel and potent ligands of the SPRY domain-containing SOCS box protein 2 (SPSB2) that binds to iNOS, and selective ligands for AGRP-binding melanocortin (MC) receptors. NP-inspired fragment absolute configuration determines the conformation of the peptide part responsible for binding. These results demonstrate that combination of NP-inspired scaffolds with peptidic epitopes enables identification of novel hot loop mimics with conformationally constrained and biologically relevant structure.

Identifiants

pubmed: 32058716
doi: 10.1021/jacs.0c00269
pmc: PMC7307906
doi:

Substances chimiques

AGRP protein, human 0
Agouti-Related Protein 0
Epitopes 0
Peptides, Cyclic 0
Receptors, Melanocortin 0
SPSB2 protein, human 0
Suppressor of Cytokine Signaling Proteins 0
NOS2 protein, human EC 1.14.13.39
Nitric Oxide Synthase Type II EC 1.14.13.39

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4904-4915

Références

J Am Chem Soc. 2010 Mar 10;132(9):2889-91
pubmed: 20155938
J Org Chem. 2018 Sep 7;83(17):10001-10014
pubmed: 29956542
J Med Chem. 2004 Dec 30;47(27):6702-10
pubmed: 15615519
J Med Chem. 2014 Dec 26;57(24):10486-98
pubmed: 25496041
Nat Chem. 2019 Mar;11(3):254-263
pubmed: 30532015
Nat Commun. 2015 May 21;6:7160
pubmed: 25994485
Org Lett. 2019 Jun 21;21(12):4709-4712
pubmed: 31188009
J Med Chem. 2018 May 10;61(9):3755-3778
pubmed: 28968506
Chem Biol. 2014 Sep 18;21(9):1102-14
pubmed: 25237857
J Am Chem Soc. 2018 Jul 18;140(28):8763-8770
pubmed: 29920073
Nat Chem. 2013 Jan;5(1):21-8
pubmed: 23247173
J Org Chem. 2007 Sep 28;72(20):7801-4
pubmed: 17824655
Nat Chem. 2016 Dec;8(12):1105-1111
pubmed: 27874866
Org Lett. 2014 Mar 7;16(5):1502-5
pubmed: 24571727
Angew Chem Int Ed Engl. 2017 Aug 21;56(35):10294-10323
pubmed: 28186380
Chemistry. 2019 May 7;25(26):6500-6504
pubmed: 30912197
Chem Commun (Camb). 2011 Jun 28;47(24):6784-94
pubmed: 21472157
Chem Rev. 2019 Sep 11;119(17):9836-9860
pubmed: 30990310
Chem Commun (Camb). 2006 Aug 28;(32):3380-9
pubmed: 16896470
J Am Chem Soc. 2019 Jun 12;141(23):9401-9407
pubmed: 31117666
J Med Chem. 2015 Jun 11;58(11):4638-47
pubmed: 25898270
J Am Chem Soc. 2005 Nov 30;127(47):16394-5
pubmed: 16305216
J Mol Biol. 2010 Aug 20;401(3):389-402
pubmed: 20561531
J Am Chem Soc. 2016 Feb 24;138(7):2098-101
pubmed: 26859098
Chem Sci. 2015 Jan 1;6(1):30-49
pubmed: 28553456
Nat Chem Biol. 2014 Sep;10(9):716-22
pubmed: 25038791
J Org Chem. 2008 May 2;73(9):3608-11
pubmed: 18363364
J Nat Prod. 2001 Sep;64(9):1169-73
pubmed: 11575950
Nat Chem Biol. 2014 Sep;10(9):723-31
pubmed: 25038790
J Org Chem. 2018 Mar 2;83(5):2744-2752
pubmed: 29384670
Science. 2017 Dec 15;358(6369):1461-1466
pubmed: 29242347
J Am Chem Soc. 2016 Oct 5;138(39):12876-12884
pubmed: 27611902
Nat Chem. 2018 Jul;10(7):715-723
pubmed: 29713035
Biochemistry. 1999 Jan 19;38(3):897-904
pubmed: 9893984
J Am Chem Soc. 2017 Apr 12;139(14):5233-5241
pubmed: 28326777
ACS Chem Biol. 2016 Jan 15;11(1):10-24
pubmed: 26575401
J Cell Biol. 2010 Jul 12;190(1):129-41
pubmed: 20603330
J Med Chem. 2016 Jun 23;59(12):5799-809
pubmed: 27214043
Nat Prod Rep. 1994 Dec;11(6):581-90
pubmed: 15209133
J Med Chem. 2015 Mar 26;58(6):2855-61
pubmed: 25695766
J Am Chem Soc. 2010 Mar 10;132(9):3063-77
pubmed: 20148556
J Am Chem Soc. 2007 Dec 26;129(51):15830-8
pubmed: 18052061
J Am Chem Soc. 2017 Sep 13;139(36):12559-12568
pubmed: 28759213
Acc Chem Res. 2014 Apr 15;47(4):1296-310
pubmed: 24730692
Chemistry. 2005 Nov 4;11(22):6687-700
pubmed: 16118822
ACS Chem Biol. 2018 Oct 19;13(10):2930-2938
pubmed: 30226743
Org Lett. 2016 Mar 18;18(6):1302-5
pubmed: 26937706
Chem Asian J. 2011 Jun 6;6(6):1546-56
pubmed: 21548101
Angew Chem Int Ed Engl. 2007;46(46):8748-58
pubmed: 17943924
J Org Chem. 2015 Jun 19;80(12):6093-101
pubmed: 25985351
J Med Chem. 2014 Aug 28;57(16):7006-15
pubmed: 25068993
Eur J Med Chem. 2016 Nov 10;123:858-894
pubmed: 27543880
Peptides. 2000 May;21(5):683-9
pubmed: 10876051
Tetrahedron Lett. 2012 Apr 18;53(16):2096-2099
pubmed: 22715296
Chem Rev. 2008 Aug;108(8):2887-902
pubmed: 18613728
J Med Chem. 2016 Sep 22;59(18):8369-80
pubmed: 27571038
Nat Rev Drug Discov. 2016 Aug;15(8):533-50
pubmed: 27050677
Chem Rev. 2019 Sep 11;119(17):9724-9752
pubmed: 31411458
Mol Cell. 2006 Dec 28;24(6):967-76
pubmed: 17189197
Chem Rev. 2019 Sep 11;119(17):10032-10240
pubmed: 31157971
Mini Rev Med Chem. 2006 Jan;6(1):11-25
pubmed: 16457629
Org Lett. 2009 May 21;11(10):2219-21
pubmed: 19419217
Biochemistry. 2001 Dec 25;40(51):15520-7
pubmed: 11747427

Auteurs

Stéphanie M Guéret (SM)

Department of Chemical Biology, AstraZeneca-Max Planck Institute Satellite Unit, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.
Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Sasikala Thavam (S)

Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.

Rodrigo J Carbajo (RJ)

Chemistry, Oncology R&D, AstraZeneca, Cambridge CB2 0SL, United Kingdom.

Marco Potowski (M)

Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.
Faculty of Chemistry and Chemical Biology, TU Dortmund University, 44227 Dortmund, Germany.

Niklas Larsson (N)

Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Göran Dahl (G)

Structure, Biophysics & Fragment Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Anita Dellsén (A)

Mechanistic Biology & Profiling, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Tom N Grossmann (TN)

Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Alleyn T Plowright (AT)

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Eric Valeur (E)

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Malin Lemurell (M)

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Herbert Waldmann (H)

Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, 44227 Dortmund, Germany.
Faculty of Chemistry and Chemical Biology, TU Dortmund University, 44227 Dortmund, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH